Perivascular cells in blood vessel regeneration

Biotechnology Journal

Volumn 8, Issue 4, 2013, Pages 434-447

  Wanjare, Maureen ^a   Kusuma, Sravanti ^a,b   Gerecht, Sharon ^a  

^a Johns Hopkins University   (United States)

^b Johns Hopkins University   (United States)

Author keywords

Pericytes; Smooth muscle cells; Tissue engineering; Vascular engineering

Indexed keywords

CELL SOURCES; CLINICAL TRANSLATION; ENGINEERING APPROACHES; PERICYTES; SMOOTH MUSCLE CELLS; TISSUE SPECIFICS; VASCULAR ENGINEERING; VASCULAR SMOOTH MUSCLE CELLS;

ENDOTHELIAL CELLS; MICROCOMPUTERS; RNA; STEM CELLS; TISSUE; TISSUE ENGINEERING;

BLOOD VESSELS;

MICRORNA;

ANGIOGENESIS; CELL FUNCTION; CELL STRAIN 3T3; CELL TYPE; CELLS; CULTURAL ANTHROPOLOGY; EMBRYONIC STEM CELL; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; FOCAL ADHESION; HUMAN; NONHUMAN; PERICYTE; PERIVASCULAR CELL; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; STEM CELL; STRESS FIBER;

ANIMALS; HUMANS; MUSCLE, SMOOTH, VASCULAR; PERICYTES; REGENERATION; TISSUE ENGINEERING;

EID: 84875795014     PISSN: 18606768     EISSN: 18607314     Source Type: Journal    
DOI: 10.1002/biot.201200199     Document Type: Review

References (134)

1. Discher, D. E., Mooney, D. J., Zandstra, P. W., Growth factors, matrices, and forces combine and control stem cells. Science 2009, 324, 1673-1677.
2. Mancini, M. L., Terzic, A., Conley, B. A., Oxburgh, L. H. et al., Endoglin plays distinct roles in vascular smooth muscle cell recruitment and regulation of arteriovenous identity during angiogenesis. Dev. Dynam. 2009, 238, 2479-2493.
3. Lindahl, P., Johansson, B. R., Levéen, P., Betsholtz, C., Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 1997, 277, 242-245.
4. Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., Walter, P., Molecular Biology of the Cell, Garland Science, New York 2002.
5. Armulik, A., Genove, G., Mae, M., Nisancioglu, M. H. et al., Pericytes regulate the blood-brain barrier. Nature 2010, 468, 557-561.
6. Drake, C. J., Embryonic and adult vasculogenesis. Birth Defects Res. Part C: Embryo Today: Rev. 2003, 69, 73-82.
7. Tepper, O. M., Capla, J. M., Galiano, R. D., Ceradini, D. J. et al., Adult vasculogenesis occurs through in situ recruitment, proliferation, and tubulization of circulating bone marrow-derived cells. Blood 2005, 105, 1068-1077.
8. Fischer, C., Schneider, M., Carmeliet, P., Principles and Therapeutic Implications of Angiogenesis, Vasculogenesis and Arteriogenesis. in: Moncada, S., Higgs, A. (Eds.), The Vascular Endothelium II, Springer, Berlin Heidelberg 2006, pp. 157-212.
9. Conway, E. M., Collen, D., Carmeliet, P., Molecular mechanisms of blood vessel growth. Cardiovas. Res. 2001, 49, 507-521.
10. Clifford, P. S., Local control of blood flow. Adv. Physiol. Educ. 2011, 35, 5-15.
11. Eble, J. A., Niland, S., The extracellular matrix of blood vessels, Curr. Pharm. Des. 2009, 15, 1385-1400.
12. Diaz-Flores, L., Gutierrez, R., Madrid, J. F., Varela, H. et al., Pericytes. Morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche. Histol. Histopathol. 2009, 24, 909-969.
13. Ball, S. G., Shuttleworth, C. A., Kielty, C. M., Platelet-derived growth factor receptors regulate mesenchymal stem cell fate: Implications for neovascularization. Exp. Opin. Biol. Ther. 2010, 10, 57-71.
14. Owens, G. K., Kumar, M. S., Wamhoff, B. R., Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev. 2004, 84, 767-801.
15. Beamish, J. A., He, P., Kottke-Marchant, K., Marchant, R. E., Molecular regulation of contractile smooth muscle cell phenotype: Implications for vascular tissue engineering. Tissue Eng., Part B 2010, 16, 467-491.
16. Lombardi, D. M., Reidy, M. A., Schwartz, S. M., Methodologic considerations important in the accurate quantitation of aortic smooth muscle cell replication in the normal rat. Am. J. Pathol. 1991, 138, 441-446.
17. Aikawa, M., Sivam, P. N., Kuro-o, M., Kimura, K. et al., Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis. Circ. Res. 1993, 73, 1000-1012.
18. Yamamoto, M., Yamamoto, K., Noumura, T., Type I collagen promotes modulation of cultured rabbit arterial smooth muscle cells from a contractile to a synthetic phenotype. Exp. Cell Res. 1993, 204, 121-129.
19. Karnik, S. K., Brooke, B. S., Bayes-Genis, A., Sorensen, L. et al., A critical role for elastin signaling in vascular morphogenesis and disease. Development 2003, 130, 411-423.
20. Mithieux, S. M., Weiss, A. S., Elastin, in: David, A. D. P., John, M. S. (Eds.), Advances in Protein Chemistry, Academic Press San Diego 2005, pp. 437-461.
21. Lin, S., Sandig, M., Mequanint, K., Three-dimensional topography of synthetic scaffolds induces elastin synthesis by human coronary artery smooth muscle cells. Tissue Eng., Part A 2011, 17, 1561-1571.
22. Frontini, M. J., Nong, Z., Gros, R., Drangova, M. et al., Fibroblast growth factor 9 delivery during angiogenesis produces durable, vasoresponsive microvessels wrapped by smooth muscle cells. Nat. Biotechnol. 2011, 29, 421-427.
23. Frink, R. J., Foundation, H. R., Inflammatory Atherosclerosis: Characteristics of the Injurious Agent, Heart Research Foundation 2002.
24. Cecchettini, A., Rocchiccioli, S., Boccardi, C., Citti, L., Chapter two - Vascular smooth-muscle-cell activation: Proteomics point of view. in: Kwang, W. J. (Ed.), International Review of Cell and Molecular Biology, Academic Press San Diego 2011, pp. 43-99.
25. Gerthoffer, W. T., Mechanisms of vascular smooth muscle cell migration. Circ. Res. 2007, 100, 607-621.
26. Ailawadi, G., Moehle, C. W., Pei, H., Walton, S. P. et al., Smooth muscle phenotypic modulation is an early event in aortic aneurysms. J. Thorac. Cardiovasc. Surg. 2009, 138, 1392-1399.
27. Cho, A., Reidy, M. A., Matrix metalloproteinase-9 is necessary for the regulation of smooth muscle cell replication and migration after arterial injury. Circ. Res. 2002, 91, 845-851.
28. Shepro, D., Morel, N. M., Pericyte physiology. FASEB J. 1993, 7, 1031-1038.
29. Armulik, A., Abramsson, A., Betsholtz, C., Endothelial/pericyte interactions. Circ. Res. 2005, 97, 512-523.
30. Crisan, M., Corselli, M., Chen, W. C., Péault, B., Perivascular cells for regenerative medicine. J. Cell. Mol. Med. 2012, 16, 2851-2860.
31. Kutcher, M. E., Kolyada, A. Y., Surks, H. K., Herman, I. M., Pericyte Rho GTPase mediates both pericyte contractile phenotype and capillary endothelial growth state. Am. J. Pathol. 2007, 171, 693-701.
32. Gonul, E., Duz, B., Kahraman, S., Kayali, H. et al., Early pericyte response to brain hypoxia in cats: An ultrastructural study. Microvasc. Res. 2002, 64, 116-119.
33. Dore-Duffy, P., Owen, C., Balabanov, R., Murphy, S. et al., Pericyte migration from the vascular wall in response to traumatic brain injury. Microvasc. Res. 2000, 60, 55-69.
34. Voisin, M.-B., Woodfin, A., Nourshargh, S., Monocytes and neutrophils exhibit both distinct and common mechanisms in penetrating the vascular basement membrane in vivo. Arterioscler. Thromb., Vasc. Biol. 2009, 29, 1193-1199.
35. Wang, S., Cao, C., Chen, Z., Bankaitis, V. et al., Pericytes regulate vascular basement membrane remodeling and govern neutrophil extravasation during inflammation. PLoS One 2012, 7, e45499.
36. Berger, M., Bergers, G., Arnold, B., Hämmerling, G. J., Ganss, R., Regulator of G-protein signaling-5 induction in pericytes coincides with active vessel remodeling during neovascularization. Blood 2005, 105, 1094-1101.
37. Caplan, A. I., All MSCs are pericytes? Cell Stem Cell 2008, 3, 229-230.
38. Crisan, M., Yap, S., Casteilla, L., Chen, C.-W. et al., A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008, 3, 301-313.
39. Körbling, M., Estrov, Z., Adult stem cells for tissue repair - A new therapeutic concept? New Engl. J. Med. 2003, 349, 570-582.
40. Caplan, A. I., Why are MSCs therapeutic? New data: New insight. J. Pathol. 2009, 217, 318-324.
41. Huang, N. F., Li, S., Mesenchymal stem cells for vascular regeneration. Regen. Med. 2008, 3, 877-892.
42. Feng, J., Mantesso, A., Sharpe, P. T., Perivascular cells as mesenchymal stem cells. Exp. Opin. Biol. Ther. 2010, 10, 1441-1451.
43. Dar, .A, Itskovitz-Eldor, J., Therapeutic potential of perivascular cells from human pluripotent stem cells. J. Tissue Eng. Regen. Med. 2013, doi: 10.1002/term.1698.
44. Kusuma, S., Gerecht, S., Comparison of induced pluripotent stem cell and embryonic stem cell differentiation toward vascular lineages. Regen. Med. 2009, 4, 805-807.
45. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M. et al., Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131, 861-872.
46. Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A. et al., Embryonic stem cell lines derived from human blastocysts. Science 1998, 282, 1145-1147.
47. Xiao, Q., Zeng, L., Zhang, Z., Hu, Y., Xu, Q., Stem cell-derived Sca-1+ progenitors differentiate into smooth muscle cells, which is mediated by collagen IV-integrin a1/ß1/av and PDGF receptor pathways. Am. J. Physiol. - Cell Physiol. 2007, 292, C342-C352.
48. Huang, H., Zhao, X., Chen, L., Xu, C. et al., Differentiation of human embryonic stem cells into smooth muscle cells in adherent monolayer culture. Biochem. Biophys. Res. Commun. 2006, 351, 321-327.
49. Sinha, S., Hoofnagle, M. H., Kingston, P. A., McCanna, M. E., Owens, G. K., Transforming growth factor-β1 signaling contributes to development of smooth muscle cells from embryonic stem cells. Am. J. Physiol. - Cell Physiol. 2004, 287, C1560-C1568.
50. Vazão, H., Neves, R. P. d., Grãos, M., Ferreira, L., Towards the maturation and characterization of smooth muscle cells derived from human embryonic stem cells. PLoS One 2011, 6, e17771.
51. Vo, E., Hanjaya-Putra, D., Zha, Y., Kusuma, S., Gerecht, S., Smooth-muscle-like cells derived from human embryonic stem cells support and augment cord-like structures in vitro. Stem Cell Rev. Rep. 2010, 6, 237-247.
52. Oyamada, N., Itoh, H., Sone, M., Yamahara, K. et al., Transplantation of vascular cells derived from human embryonic stem cells contributes to vascular regeneration after stroke in mice. J. Trans. Med. 2008, 6, 54.
53. Taura, D., Sone, M., Homma, K., Oyamada, N. et al., Induction and isolation of vascular cells from human induced pluripotent stem cells - Brief report. Arteriosclerosis, Thrombosis, Vasc. Biol. 2009, 29, 1100-1103.
54. Lee, T.-H., Song, S.-H., Kim, K. L., Yi, J.-Y. et al., Functional recapitulation of smooth muscle cells via induced pluripotent stem cells from human aortic smooth muscle cells. Circ. Res. 2010, 106, 120-128.
55. Bajpai, V. K., Mistriotis, P., Loh, Y.-H., Daley, G. Q., Andreadis, S. T., Functional vascular smooth muscle cells derived from human induced pluripotent stem cells via mesenchymal stem cell intermediates. Cardiovasc. Res. 2012, 96, 391-400.
56. Tang, Z., Wang, A., Yuan, F., Yan, Z. et al., Differentiation of multipotent vascular stem cells contributes to vascular diseases. Nat. Commun. 2012, 3, 875.
57. Dar, A., Domev, H., Ben-Yosef, O., Tzukerman, M. et al., Multipotent vasculogenic pericytes from human pluripotent stem cells promote recovery of murine ischemic limb/clinical perspective. Circulation 2012, 125, 87-99.
58. Yamashita, J., Itoh, H., Hirashima, M., Ogawa, M. et al., Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 2000, 408, 92-96.
59. Crisan, M., Chen, C.-W., Corselli, M., Andriolo, G. et al., Perivascular multipotent progenitor cells in human organs. Ann. N. Y. Acad. Sci. 2009, 1176, 118-123.
60. Farrington-Rock, C., Crofts, N. J., Doherty, M. J., Ashton, B. A. et al., Chondrogenic and adipogenic potential of microvascular pericytes. Circulation 2004, 110, 2226-2232.
61. Stratman, A. N., Malotte, K. M., Mahan, R. D., Davis, M. J., Davis, G. E., Pericyte recruitment during vasculogenic tube assembly stimulates endothelial basement membrane matrix formation. Blood 2009, 114, 5091-5101.
62. Harvey, K., Welch, Z., Sliva, D., Siddiqui, R., Role of Rho kinase in sphingosine 1-phosphate-mediated endothelial and smooth muscle cell migration and differentiation. Mol. Cell. Biochem. 2010, 342, 7-19.
63. Moon, J. J., Saik, J. E., Poché, R. A., Leslie-Barbick, J. E. et al., Biomimetic hydrogels with pro-angiogenic properties. Biomaterials 2010, 31, 3840-3847.
64. Heydarkhan-Hagvall, S., Helenius, G., Johansson, B. R., Li, J. Y. et al., Co-culture of endothelial cells and smooth muscle cells affects gene expression of angiogenic factors. J. Cell. Biochem. 2003, 89, 1250-1259.
65. Darland, D. C., Massingham, L. J., Smith, S. R., Piek, E. et al., Pericyte production of cell-associated VEGF is differentiation-dependent and is associated with endothelial survival. Dev. Biol. 2003, 264, 275-288.
66. Sakamoto, N., Kiuchi, T., Sato, M., Development of an endothelial-smooth muscle cell coculture model using phenotype-controlled smooth muscle cells. Ann. Biomed. Eng. 2011, 39, 2750-2758.
67. Orlidge, A., D'Amore, P. A., Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J. Cell Biol. 1987, 105, 1455-1462.
68. Stratman, A. N., Schwindt, A. E., Malotte, K. M., Davis, G. E., Endothelial-derived PDGF-BB and HB-EGF coordinately regulate pericyte recruitment during vasculogenic tube assembly and stabilization. Blood 2010, 116, 4720-4730.
69. Han, M., Wen, J.-K., Zheng, B., Cheng, Y., Zhang, C., Serum deprivation results in redifferentiation of human umbilical vascular smooth muscle cells. Am. J. Physiol. - Cell Physiol. 2006, 291, C50-C58.
70. Wernig, F., Mayr, M., Xu, Q., Mechanical stretch-induced apoptosis in smooth muscle cells is mediated by β1-integrin signaling pathways. Hypertension 2003, 41, 903-911.
71. McDonald, O. G., Wamhoff, B. R., Hoofnagle, M. H., Owens, G. K., Control of SRF binding to CArG box chromatin regulates smooth muscle gene expression in vivo. J. Clin. Invest. 2006, 116, 36-48.
72. Kaplan-Albuquerque, N., Van Putten, V., Weiser-Evans, M. C., Nemenoff, R. A., Depletion of serum response factor by RNA interference mimics the mitogenic effects of platelet derived growth factor-BB in vascular smooth muscle cells. Circ. Res. 2005, 97, 427-433.
73. Yoshida, T., Sinha, S., Dandré, F., Wamhoff, B. R. et al., Myocardin is a key regulator of CArG-dependent transcription of multiple smooth muscle marker genes. Circ. Res. 2003, 92, 856-864.
74. Raphel, L., Talasila, A., Cheung, C., Sinha, S., Myocardin overexpression is sufficient for promoting the development of a mature smooth muscle cell-like phenotype from human embryonic stem cells. PLoS One 2012, 7, e44052.
75. Wanjare, M., Kuo, F., Gerecht, S., Derivation and maturation of synthetic and contractile vascular smooth muscle cells from human pluripotent stem cells. Cardiovasc. Res. 2012.
76. Lee, S.-M., Vasishtha, M., Prywes, R., Activation and repression of cellular immediate early genes by serum response factor cofactors. J. Biol. Chem. 2010, 285, 22036-22049.
77. Wang, Z., Wang, D.-Z., Hockemeyer, D., McAnally, J. et al., Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression. Nature 2004, 428, 185-189.
78. Liu, Y., Sinha, S., McDonald, O. G., Shang, Y. et al., Kruppel-like factor 4 abrogates myocardin-induced activation of smooth muscle gene expression. J. Biol. Chem. 2005, 280, 9719-9727.
79. Kiyan, Y., Limbourg, A., Kiyan, R., Tkachuk, S. et al., Urokinase receptor associates with myocardin to control vascular smooth muscle cells phenotype in vascular disease. Arteriosclerosis, Thrombosis, Vasc. Biol. 2012, 32, 110-122.
80. Massagué, J., TGF-β signal transduction. Ann. Rev. Biochem. 1998, 67, 753-791.
81. Klein, D., Weißhardt, P., Kleff, V., Jastrow, H. et al., Vascular wall-resident CD44+ multipotent stem cells give rise to pericytes and smooth muscle cells and contribute to new vessel maturation. PLoS One 2011, 6, e20540.
82. Carvalho, R. L. C., Jonker, L., Goumans, M.-J., Larsson, J. et al., Defective paracrine signalling by TGFß in yolk sac vasculature of endoglin mutant mice: A paradigm for hereditary haemorrhagic telangiectasia. Development 2004, 131, 6237-6247.
83. Deaton, R. A., Su, C., Valencia, T. G., Grant, S. R., Transforming growth factor-ß1-induced expression of smooth muscle marker genes involves activation of PKN and p38 MAPK. J. Biol. Chem. 2005, 280, 31172-31181.
84. Sieczkiewicz, G. J., Herman, I. M., TGF-β1 signaling controls retinal pericyte contractile protein expression. Microvasc. Res. 2003, 66, 190-196.
85. Holycross, B. J., Blank, R. S., Thompson, M. M., Peach, M. J., Owens, G. K., Platelet-derived growth factor-BB-induced suppression of smooth muscle cell differentiation. Circ. Res. 1992, 71, 1525-1532.
86. Dandré, F., Owens, G. K., Platelet-derived growth factor-BB and Ets-1 transcription factor negatively regulate transcription of multiple smooth muscle cell differentiation marker genes. Am. J. Physiol. - Heart Circ. Physiol. 2004, 286, H2042-H2051.
87. Deaton, R. A., Gan, Q., Owens, G. K., Sp1-dependent activation of KLF4 is required for PDGF-BB-induced phenotypic modulation of smooth muscle. Am. J. Physiol. - Heart Circ. Physiol. 2009, 296, H1027-H1037.
88. Benjamin, L. E., Hemo, I., Keshet, E., A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 1998, 125, 1591-1598.
89. Hellström, M., Kalén, M., Lindahl, P., Abramsson, A., Betsholtz, C., Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 1999, 126, 3047-3055.
90. Yamagishi, S. I., Yonekura, H., Yamamoto, Y., Fujimori, H. et al., Vascular endothelial growth factor acts as a pericyte mitogen under hypoxic conditions. Lab. Invest. 1999, 79, 501-509.
91. Kerkar, S., Williams, M., Blocksom, J. M., Wilson, R. F. et al., TNF-α and IL-1β increase pericyte/endothelial cell co-culture permeability. J. Surg. Res. 2006, 132, 40-45.
92. Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S. et al., Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997, 277, 55-60.
93. Kobayashi, H., DeBusk, L. M., Babichev, Y. O., Dumont, D. J., Lin, P. C., Hepatocyte growth factor mediates angiopoietin-induced smooth muscle cell recruitment. Blood 2006, 108, 1260-1266.
94. Hammes, H.-P., Lin, J., Wagner, P., Feng, Y. et al., Angiopoietin-2 causes pericyte dropout in the normal retina. Diabetes 2004, 53, 1104-1110.
95. Daubman, S., MicroRNAs in angiogenesis and vascular smooth muscle cell function. Circ. Res. 2010, 106, 423-425.
96. Cordes, K. R., Sheehy, N. T., White, M. P., Berry, E. C. et al., miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 2009, 460, 705-710.
97. Boucher, J. M., Peterson, S. M., Urs, S., Zhang, C., Liaw, L., The miR-143/145 cluster is a novel transcriptional target of jagged-1/notch signaling in vascular smooth muscle cells. J. Biol. Chem. 2011, 286, 28312-28321.
98. Cheng, Y., Liu, X., Yang, J., Lin, Y. et al., MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ. Res. 2009, 105, 158-166.
99. Wang, Y.-S., Wang, H.-Y. J., Liao, Y.-C., Tsai, P.-C. et al., MicroRNA-195 regulates vascular smooth muscle cell phenotype and prevents neointimal formation. Cardiovasc. Res. 2012, 95, 517-526.
100. Torella, D., Iaconetti, C., Catalucci, D., Ellison, G. M. et al., MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo/novelty and significance. Circ. Res. 2011, 109, 880-893.
101. Kang, H., Davis-Dusenbery, B. N., Nguyen, P. H., Lal, A. et al., Bone morphogenetic protein 4 promotes vascular smooth muscle contractility by activating MicroRNA-21 (miR-21), which down-regulates expression of family of dedicator of cytokinesis (DOCK) proteins. J. Biol. Chem. 2012, 287, 3976-3986.
102. Davis, B. N., Hilyard, A. C., Lagna, G., Hata, A., SMAD proteins control DROSHA-mediated microRNA maturation. Nature 2008, 454, 56-61.
103. Wang, M., Li, W., Chang, G.-Q., Ye, C.-S. et al., MicroRNA-21 regulates vascular smooth muscle cell function via targeting tropomyosin 1 in arteriosclerosis obliterans of lower extremities. Arteriosclerosis, Thrombosis, Vasc. Biol. 2011, 31, 2044-2053.
104. Sarkar, J., Gou, D., Turaka, P., Viktorova, E. et al., MicroRNA-21 plays a role in hypoxia-mediated pulmonary artery smooth muscle cell proliferation and migration. Am. J. Physiol. - Lung Cell. Mol. Physiol. 2010, 299, L861-L871.
105. Liu, X., Cheng, Y., Zhang, S., Lin, Y. et al., A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ. Res. 2009, 104, 476-487.
106. Larsson, E., Fuchs, P. F., Heldin, J., Barkefors, I. et al., Discovery of microvascular miRNAs using public gene expression data: MiR-145 is expressed in pericytes and is a regulator of Fli1. Genome Med. 2009, 1, 108.
107. Shi, Z.-D., Tarbell, J., Fluid flow mechanotransduction in vascular smooth muscle cells and fibroblasts. Ann. Biomed. Eng. 2011, 39, 1608-1619.
108. Wang, D. M., Tarbell, J. M., Modeling interstitial flow in an artery wall allows estimation of wall shear stress on smooth muscle cells. J. Biomech. Eng. 1995, 117, 358-363.
109. Shi, Z.-D., Ji, X.-Y., Qazi, H., Tarbell, J. M., Interstitial flow promotes vascular fibroblast, myofibroblast, and smooth muscle cell motility in 3-D collagen I via upregulation of MMP-1. Am. J. Physiol. - Heart Circ. Physiol. 2009, 297, H1225-H1234.
110. Tada, S., Tarbell, J. M., Interstitial flow through the internal elastic lamina affects shear stress on arterial smooth muscle cells. Am. J. Physiol. - Heart Circ. Physiol. 2000, 278, H1589-H1597.
111. Lee, A. A., Graham, D. A., Dela Cruz, S., Ratcliffe, A., Karlon, W. J., Fluid shear stress-induced alignment of cultured vascular smooth muscle cells. J. Biomech. Eng. 2002, 124, 37-43.
112. Opitz, F., Schenke-Layland, K., Cohnert, T. U., Stock, U. A., Phenotypical plasticity of vascular smooth muscle cells-effect of in vitro and in vivo shear stress for tissue engineering of blood vessels. Tissue Eng. 2007, 13, 2505-2514.
113. Papadaki, M., McIntire, L. V., Eskin, S. G., Effects of shear stress on the growth kinetics of human aortic smooth muscle cells in vitro. Biotechnol. Bioeng. 1996, 50, 555-561.
114. Anwar, M. A., Shalhoub, J., Lim, C. S., Gohel, M. S., Davies, A. H., The effect of pressure-induced mechanical stretch on vascular wall differential gene expression. J. Vasc. Res. 2012, 49, 463-478.
115. Park, J. S., Chu, J. S. F., Cheng, C., Chen, F. et al., Differential effects of equiaxial and uniaxial strain on mesenchymal stem cells. Biotechnol. Bioeng. 2004, 88, 359-368.
116. Tock, J., Van Putten, V., Stenmark, K. R., Nemenoff, R. A., Induction of SM-a-actin expression by mechanical strain in adult vascular smooth muscle cells is mediated through activation of JNK and p38 MAP kinase. Biochem. Biophys. Res. Commun. 2003, 301, 1116-1121.
117. Qu, M. J., Liu, B., Wang, H. Q., Yan, Z. Q. et al., Frequency-dependent phenotype modulation of vascular smooth muscle cells under cyclic mechanical strain. J. Vasc. Res. 2007, 44, 345-353.
118. Liu, B., Qu, M.-J., Qin, K.-R., Li, H. et al., Role of cyclic strain frequency in regulating the alignment of vascular smooth muscle cells in vitro. Biophys. J. 2008, 94, 1497-1507.
119. Joki, N., Kaname, S., Hirakata, M., Hori, Y. et al., Tyrosine-kinase dependent TGF-β and extracellular matrix expression by mechanical stretch in vascular smooth muscle cells. Hypertens. Res. 2000, 23, 91-99.
120. O'Callaghan, C. J., Williams, B., Mechanical strain-induced extracellular matrix production by human vascular smooth muscle cells. Hypertension 2000, 36, 319-324.
121. Isenberg, B. C., Tranquillo, R. T., Long-term cyclic distention enhances the mechanical properties of collagen-based media-equivalents. Ann. Biomed. Eng. 2003, 31, 937-949.
122. Jeong, S. I., Kwon, J. H., Lim, J. I., Cho, S.-W. et al., Mechano-active tissue engineering of vascular smooth muscle using pulsatile perfusion bioreactors and elastic PLCL scaffolds. Biomaterials 2005, 26, 1405-1411.
123. Wang, C., Cen, L., Yin, S., Liu, Q. et al., A small diameter elastic blood vessel wall prepared under pulsatile conditions from polyglycolic acid mesh and smooth muscle cells differentiated from adipose-derived stem cells. Biomaterials 2010, 31, 621-630.
124. Xu, Z. C., Zhang, W. J., Li, H., Cui, L. et al., Engineering of an elastic large muscular vessel wall with pulsatile stimulation in bioreactor. Biomaterials 2008, 29, 1464-1472.
125. Thakar, R. G., Cheng, Q., Patel, S., Chu, J. et al., Cell-shape regulation of smooth muscle cell proliferation. Biophys. J. 2009, 96, 3423-3432.
126. Thakar, R. G., Ho, F., Huang, N. F., Liepmann, D., Li, S., Regulation of vascular smooth muscle cells by micropatterning. Biochem. Biophys. Res. Commun. 2003, 307, 883-890.
127. Williams, C., Brown, X. Q., Bartolak-Suki, E., Ma, H. et al., The use of micropatterning to control smooth muscle myosin heavy chain expression and limit the response to transforming growth factor β1 in vascular smooth muscle cells. Biomaterials 2011, 32, 410-418.
128. Peyton, S. R., Kim, P. D., Ghajar, C. M., Seliktar, D., Putnam, A. J., The effects of matrix stiffness and RhoA on the phenotypic plasticity of smooth muscle cells in a 3-D biosynthetic hydrogel system. Biomaterials 2008, 29, 2597-2607.
129. Moussallem, M. D., Olenych, S. G., Scott, S. L., Keller, T. C. S., Schlenoff, J. B., Smooth muscle cell phenotype modulation and contraction on native and cross-linked polyelectrolyte multilayers. Biomacromolecules 2009, 10, 3062-3068.
130. Brown, X. Q., Bartolak-Suki, E., Williams, C., Walker, M. L. et al., Effect of substrate stiffness and PDGF on the behavior of vascular smooth muscle cells: Implications for atherosclerosis. J. Cell. Physiol. 2010, 225, 115-122.
131. Liu, Y., Chan-Park, M. B., A biomimetic hydrogel based on methacrylated dextran-graft-lysine and gelatin for 3D smooth muscle cell culture. Biomaterials 2010, 31, 1158-1170.
132. Robinson, H. C., Baker, A. H., How do microRNAs affect vascular smooth muscle cell biology? Curr. Opin. Lipidol. 2012, 23, 405-411.
133. Švorčík, V., Kolářová, K., Slepička, P., Macková, A. et al., Modification of surface properties of high and low density polyethylene by Ar plasma discharge. Polym. Degrad. Stab. 2006, 91, 1219-1225.
134. Bailey, S. R. M., Flavahan, S., Bergdall, V. K., Flavahan, N. A., In vivo endothelial denudation disrupts smooth muscle caveolae and differentially impairs agonist-induced constriction in small arteries. J. Cardiovasc. Pharm. 2007, 49, 183-190.